Osaic Holdings’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$164K Sell
873
-14
-2% -$2.7K ﹤0.01% 4302
2025
Q4
$168K Sell
887
-414
-32% -$76.6K ﹤0.01% 4289
2025
Q3
$213K Sell
1,301
-164
-11% -$26.7K ﹤0.01% 4154
2025
Q2
$225K Buy
1,465
+682
+87% +$102K ﹤0.01% 3842
2025
Q1
$123K Buy
783
+245
+46% +$39.8K ﹤0.01% 4022
2024
Q4
$84.4K Sell
538
-53
-9% -$8.92K ﹤0.01% 4310
2024
Q3
$105K Sell
591
-277
-32% -$49.1K ﹤0.01% 4185
2024
Q2
$146K Sell
868
-1,134
-57% -$185K ﹤0.01% 3825
2024
Q1
$333K Sell
2,002
-245
-11% -$40.6K ﹤0.01% 3263
2023
Q4
$372K Sell
2,247
-212
-9% -$32.6K ﹤0.01% 3405
2023
Q3
$383K Buy
2,459
+248
+11% +$39.6K ﹤0.01% 3483
2023
Q2
$345K Sell
2,211
-138
-6% -$22K ﹤0.01% 3471
2023
Q1
$381K Buy
2,349
+58
+3% +$9.38K ﹤0.01% 3328
2022
Q4
$366K Buy
2,291
+146
+7% +$23.1K ﹤0.01% 3314
2022
Q3
$302K Buy
2,145
+5
+0.2% +$756 ﹤0.01% 3376
2022
Q2
$312K Sell
2,140
-1,414
-40% -$211K ﹤0.01% 3389
2022
Q1
$549K Sell
3,554
-193
-5% -$31.3K ﹤0.01% 3143
2021
Q4
$708K Buy
3,747
+1,398
+60% +$270K ﹤0.01% 2718
2021
Q3
$476K Sell
2,349
-178
-7% -$37.4K ﹤0.01% 3082
2021
Q2
$510K Sell
2,527
-805
-24% -$150K ﹤0.01% 3019
2021
Q1
$585K Buy
3,332
+1,102
+49% +$199K ﹤0.01% 2714
2020
Q4
$378K Sell
2,230
-107
-5% -$17.6K ﹤0.01% 2902
2020
Q3
$379K Sell
2,337
-55
-2% -$8.94K ﹤0.01% 2689
2020
Q2
$389K Buy
2,392
+324
+16% +$49.2K ﹤0.01% 2550
2020
Q1
$198K Buy
+2,068
New +$279K ﹤0.01% 2866

Other funds holding BBH

Osaic Holdings's BBH Position: Q1 2026 in Review

Osaic Holdings reduced its VanEck Biotech ETF (BBH) stake by 1.6% in Q1 2026, selling an estimated $2.7K and leaving 873 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #4302.

Osaic Holdings first reported a position in BBH in Q1 2020 and has held it in 25 quarters since. The position peaked at $708K in Q4 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Osaic Holdings held 873 shares of VanEck Biotech ETF worth $164K as of Q1 2026.
  • Osaic Holdings sold 14 VanEck Biotech ETF shares in Q1 2026, an estimated $2.7K.
  • VanEck Biotech ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #4302 holding.
  • Osaic Holdings first reported a position in VanEck Biotech ETF in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's VanEck Biotech ETF position peaked at $708K in Q4 2021.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.